Vikram Solar Limited (VIKRAMSOLR)
Investor Presentation
Investor Presentation - Q2FY27
- Sales volume 591 MW, down 24.6% y-y and 41.2% q-q; H1 volume up 3.1% y-y to 1,596 MW
- Revenue ₹1,077 Cr, down 2.9% y-y and 31.1% q-q; H1 revenue up 17.7% y-y to ₹2,641 Cr
- EBITDA ₹101 Cr, margin 9.4%, down 11.78 pts y-y; H1 EBITDA ₹227 Cr, margin 8.6%, down 12.66 pts y-y
- Order book increased 4% q-q to 8.2 GW with 1.7 GW new orders in Q2
- Cell plant on track for Dec 2026 first cell out and Mar 2027 commercial production
- Distribution volume up 80% q-q to 259 MW; DCR volume up 71% q-q to 130 MW
- BESS assembly plant to start commercial operations Apr 2027 with 7.5 GWh capacity
- Integration milestones progressing to improve margins and expand supply
- Industry outlook strong with solar demand growth and policy support
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 VIKRAMSOLR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add VIKRAMSOLR to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Vikram Solar Limited
Important.
The summary above is generated automatically from Vikram Solar Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.